Development and research of the new dosage form Imunofan, rectal suppository 0,1 mg

In this work the author compared the results obtained on research of bioavailability of the new developed form Imunofan, rectal suppository 0,1 mg and "Imunofan, a solution for injections 0,005 %. On the basis of the data obtained the bioavailability of Imunofan at rectal introduction does not concede bioavailability of Imunofan at intramuscular introduction. In this way the author has proved a choice of the new dosage form immunomodulator of new generation - Imunofan.